The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Latest research progress in biomarkers of heart failure
Author(s): 
Pages: 670-675
Year: Issue:  11
Journal: Qilu Pharmaceutical Affairs

Keyword:  心力衰竭生物标志物临床应用危险分层预后评估;
Abstract: 心力衰竭是一种复杂的临床综合症,在全球具有较高的发病率和死亡率.良好的生物标志物有助于疾病的危险分层和预后评估.目前利钠肽是唯一的生物标志物被录入心力衰竭的指南.近年来多种与心力衰竭病理过程相关的生物标志物相继出现,与纤维化相关的、与心肌细胞损伤相关的、与细胞基质重塑相关的等,这些生物标志物对心力衰竭的筛查鉴别以及疾病危险分层和预后评估都有一定的价值,本文将对这些生物标志物的进行总结分析.
Related Articles
No related articles found